| Zhang, Qing |
NCT05181137 / 2021-001940-86: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis |
|
|
| Recruiting | 3 | 368 | Europe, US, RoW | SHR0302, Placebo | Reistone Biopharma Company Limited, Reistone Biopharma Company Limited | Ulcerative Colitis | 10/24 | 03/25 | | |
| Recruiting | 3 | 314 | RoW | Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502), Control drug: Trastuzumab emtansine (Kadcyla, T-DM1) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Breast Cancer | 07/25 | 01/26 | | |
| Recruiting | 3 | 2100 | Europe, Canada, Japan, US, RoW | Rimegepant/BHV3000, Matching placebo | Pfizer | Pediatric Migraine | 01/29 | 01/29 | | |
NCT05133856: A Study of TAF in Combination With PEG-IFN and Hepalatide in Subjects With Chronic Hepatitis B |
|
|
| Not yet recruiting | 2 | 30 | RoW | hepalatide, L47, Pegylated Interferon, PegIFN-alpha-2a, TAF, Vemlidy, Placebo | Shanghai HEP Pharmaceatical Co., Ltd. | Hepatitis B, Chronic | 12/23 | 06/24 | | |
NCT06289751: Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer |
|
|
| Recruiting | 2 | 50 | RoW | Cadonilimab, Cadonilimab Injection, AK104, Paclitaxel-albumin, Injectable paclitaxel (albumin bound), Cisplatin, Cisplatin injection, Extrafascial hysterectomy, Radical hysterectomy, Cone biopsy | Tongji Hospital, The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial), Women Hospital, School of Medicine, Zhejiang University, Southwest Hospital, China, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sichuan Cancer Hospital and Research Institute, Qilu Hospital of Shandong University, Beijing Friendship Hospital, Tianjin Medical University, West China Second University Hospital, Xiangya Hospital of Central South University, Gansu Provincial Maternal and Child Health Care Hospital, Zhejiang Cancer Hospital, Shengjing Hospital | Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy, Extrafascial Hysterectomy | 03/26 | 01/31 | | |
| Recruiting | 2 | 54 | RoW | proton plus carbon ion radiation | Shanghai Proton and Heavy Ion Center | Prostate Cancer | 05/25 | 05/26 | | |
NCT05938374: Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma |
|
|
| Recruiting | 2 | 100 | RoW | Fluzoparib, RT+Fluzoparib, Preoperative moderately fractionated radiotherapay, RT | Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Jishuitan Hospital | Soft Tissue Sarcoma | 04/26 | 12/26 | | |
| Recruiting | 1 | 51 | RoW | CM313 injection | Keymed Biosciences Co.Ltd | Healthy | 04/25 | 04/25 | | |
NCT06298266: To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma |
|
|
| Not yet recruiting | 1 | 15 | RoW | infusion of GPRC5D-CD19 CAR T injection | Guangdong Second Provincial General Hospital | Relapsed or Refractory Multiple Myeloma | 05/26 | 12/26 | | |
NCT06045585: JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma |
|
|
| Recruiting | 1 | 20 | RoW | infusion of JY231 injection | Guangdong Second Provincial General Hospital | Relapsed or Refractory B-cell Lymphoma | 08/25 | 12/25 | | |
NCT04969354: Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell Carcinoma |
|
|
| Recruiting | 1 | 20 | RoW | CAR-T cell immunotherapy | The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University | Immunotherapy | 09/25 | 09/26 | | |
| Recruiting | 1 | 20 | RoW | CAR-T cell immunotherapy | The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University | Immunotherapy | 11/25 | 11/26 | | |
NCT02739659: Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer |
|
|
| Recruiting | N/A | 73 | RoW | carbon-ion radiotherapy | Shanghai Proton and Heavy Ion Center | Prostate Carcinoma | 12/22 | 12/24 | | |
NCT05193331: Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye |
|
|
| Not yet recruiting | N/A | 70 | RoW | 3% Diquafosol tetrasodium, Diquas | He Eye Hospital, Santen Pharmaceutical(China) Co.,LTD | Diabetic Eye Problems | 08/23 | 11/23 | | |
NCT04980144: Diquafosol Ophthalmic Solution for Dry Eye Symptoms |
|
|
| Not yet recruiting | N/A | 101 | RoW | 3% Diquafosol tetrasodium, Diquas, 0.1% hyaluronate, Artificial tears | He Eye Hospital | Diabetic Eye Problems | 08/23 | 11/23 | | |
NCT06158984: Managing Dry Eye in Patients Using Glaucoma Drops |
|
|
| Completed | N/A | 60 | RoW | IPL, Intense pulsed light | He Eye Hospital | Dry Eye | 12/23 | 12/23 | | |
NCT06158997: Safety and Effectiveness of EyePeace on Signs and Symptoms of Dry Eye Disease |
|
|
| Not yet recruiting | N/A | 60 | RoW | EyePeace, Eye massager, Heated Eye Mask, HEM | He Eye Hospital | Evaporative Dry Eye | 02/24 | 04/24 | | |
NCT05330923: Effect of NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients |
|
|
| Recruiting | N/A | 200 | RoW | | Peking Union Medical College Hospital, Wuxi Hisky Medical Technology Co Ltd | Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Fibrosis, HIV/AIDS | 05/25 | 01/27 | | |
NCT05597566: Predictive Effect of Neuroinflammatory Factors of the MECT in Treatment of Senile Depression |
|
|
| Recruiting | N/A | 72 | RoW | modified electroconvulsive therapy | Qinge Zhang | Major Depression Disorder | 10/22 | 12/22 | | |
